Concepedia

Jiejun Wu

JW

42

Publications

3.3K

Citations

27

H-Index

1987

Active since

Affiliations

Johnson & Johnson (United States)(Current)

Janssen (United States)

The Ohio State University

Cancer Genetics (United States)

Jiejun Wu is an author at Johnson & Johnson (United States) specializing in medicine, pharmacology, and biochemistry.

ORCID

Top concepts

Publications per year

1987–2021

42

Publications

42

Lactate Inhibits Lipolysis in Fat Cells through Activation of an Orphan G-protein-coupled Receptor, GPR81

Changlu Liu, Jiejun Wu, Jessica Zhu et al. · Journal of Biological Chemistry · 2008 · 570 citations · Full text

Oxysterols direct B-cell migration through EBI2

Changlu Liu, Xia V. Yang, Jiejun Wu et al. · Nature · 2011 · 374 citations

, , +3

Oxysterols are agonist ligands of RORγt and drive Th17 cell differentiation

Pejman Soroosh, Jiejun Wu, Xiaohua Xue et al. · Proceedings of the National Academy of Sciences · 2014 · 242 citations · Full text

, , +26

INSL5 Is a High Affinity Specific Agonist for GPCR142 (GPR100)

Changlu Liu, Chester Kuei, Steven W. Sutton et al. · Journal of Biological Chemistry · 2004 · 193 citations · Full text

Commensal bacteria contribute to insulin resistance in aging by activating innate B1a cells

Monica Bodogai, Jennifer O’Connell, Ki H. Kim et al. · Science Translational Medicine · 2018 · 177 citations · Full text

Rows per page

1–5 of 42